Stock ALBERTDAVD ALBERT DAVID LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Albert David Limited NSE India S.E.

Equities

ALBERTDAVD

INE155C01010

Pharmaceuticals

Delayed NSE India S.E.
Other stock markets
 05:59:38 2024-05-03 am EDT 		5-day change 1st Jan Change
1,170 INR +1.62% Intraday chart for Albert David Limited -2.32% +19.99%
Mar. 31 Albert David Limited Announces Board Retirement CI
Mar. 14 Albert David Limited Announces Management Changes CI

Valuation

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Capitalization 1 2,080 2,249 1,836 2,150 3,034 2,921
Enterprise Value (EV) 1 1,612 1,269 816.5 677.4 1,343 942.3
P/E ratio 21.1 x 8.44 x 9.58 x 9.71 x 8.61 x 8.08 x
Yield 1.51% 1.52% 2.18% 1.59% 1.69% 1.76%
Capitalization / Revenue 0.72 x 0.71 x 0.57 x 0.87 x 0.97 x 0.86 x
EV / Revenue 0.56 x 0.4 x 0.25 x 0.27 x 0.43 x 0.28 x
EV / EBITDA 6.96 x 4.27 x 2.47 x 3.82 x 3.43 x 2.18 x
EV / FCF 6.12 x 3.53 x 7.49 x 1.98 x 3.58 x -21.4 x
FCF Yield 16.3% 28.3% 13.4% 50.4% 28% -4.68%
Price to Book 1.12 x 1.07 x 0.82 x 0.88 x 1.09 x 0.94 x
Nbr of stocks (in thousands) 5,707 5,707 5,707 5,707 5,707 5,707
Reference price 2 364.4 394.0 321.8 376.8 531.6 511.9
Announcement Date 8/9/18 7/11/19 9/1/20 8/20/21 7/14/22 5/19/23
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net sales 1 2,874 3,169 3,208 2,474 3,135 3,416
EBITDA 1 231.6 297.2 330.2 177.4 391.5 431.6
EBIT 1 148.1 227.6 261.5 109.2 319.9 362.4
Operating Margin 5.15% 7.18% 8.15% 4.41% 10.2% 10.61%
Earnings before Tax (EBT) 1 215.4 288.5 289.5 274.4 473 507.4
Net income 1 98.41 266.4 191.7 221.4 352.6 361.7
Net margin 3.42% 8.41% 5.98% 8.95% 11.25% 10.59%
EPS 2 17.24 46.68 33.59 38.80 61.78 63.39
Free Cash Flow 1 263.5 359.5 109 341.7 375.4 -44.1
FCF margin 9.17% 11.35% 3.4% 13.81% 11.97% -1.29%
FCF Conversion (EBITDA) 113.75% 120.98% 33.01% 192.59% 95.89% -
FCF Conversion (Net income) 267.76% 134.96% 56.88% 154.31% 106.47% -
Dividend per Share 2 5.500 6.000 7.000 6.000 9.000 9.000
Announcement Date 8/9/18 7/11/19 9/1/20 8/20/21 7/14/22 5/19/23
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 468 980 1,020 1,473 1,691 1,979
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 263 360 109 342 375 -44.1
ROE (net income / shareholders' equity) 7.31% 8.94% 8.85% 9.48% 13.5% 12.2%
ROA (Net income/ Total Assets) 3.23% 4.86% 5.32% 2.06% 5.37% 5.49%
Assets 1 3,049 5,479 3,606 10,736 6,562 6,586
Book Value Per Share 2 326.0 369.0 390.0 428.0 490.0 546.0
Cash Flow per Share 2 44.50 12.00 11.20 8.890 3.990 2.530
Capex 1 37.7 19.6 154 16.3 111 52.4
Capex / Sales 1.31% 0.62% 4.81% 0.66% 3.53% 1.53%
Announcement Date 8/9/18 7/11/19 9/1/20 8/20/21 7/14/22 5/19/23
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Generic Pharmaceuticals

1st Jan change Capi.
SUN PHARMACEUTICAL INDUSTRIES LTD. Stock Sun Pharmaceutical Industries Ltd.
+19.66% 43.67B
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+20.67% 22.51B
SANDOZ GROUP AG Stock Sandoz Group AG
+14.26% 14.6B
CIPLA LIMITED Stock Cipla Limited
+14.35% 13.74B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+43.65% 11.91B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-8.37% 7.04B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+10.21% 5.42B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. ALBERTDAVD Stock
  4. ALBERTDAVD Stock
  5. Financials Albert David Limited